139 related articles for article (PubMed ID: 2999501)
1. [Chickenpox prevention in patients at risk with a special immunoglobulin].
Thomas E; Enders-Ruckle G; Geursen RG
Klin Padiatr; 1985; 197(5):415-8. PubMed ID: 2999501
[TBL] [Abstract][Full Text] [Related]
2. Management of varicella-zoster contact and infection in pregnancy using a standardized varicella-zoster ELISA test.
Enders G
Postgrad Med J; 1985; 61 Suppl 4():23-30. PubMed ID: 3014475
[TBL] [Abstract][Full Text] [Related]
3. Varicella-zoster immune globulin for the prevention of chickenpox.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1984 Feb; 33(7):84-90, 95-100. PubMed ID: 6422250
[No Abstract] [Full Text] [Related]
4. [Use of specific intravenous varicella-zoster immunoglobulins in the prevention of varicella in immunocompromised children: clinical and serological evaluation].
Macchia P; Favre C; Nardi M; Consolini R; Conaldi PG; Bendinelli M
Minerva Pediatr; 1987 Oct; 39(20):813-20. PubMed ID: 2830480
[No Abstract] [Full Text] [Related]
5. Varicella in pediatric renal transplant recipients.
Lynfield R; Herrin JT; Rubin RH
Pediatrics; 1992 Aug; 90(2 Pt 1):216-20. PubMed ID: 1322522
[TBL] [Abstract][Full Text] [Related]
6. [Use of Varitect in the prevention of diseases in children caused by varicella-zoster viruses].
Bartosová D; Wiedermannová D
Cesk Pediatr; 1993 May; 48(5):275-7. PubMed ID: 8374966
[TBL] [Abstract][Full Text] [Related]
7. [Varicella zoster immunoglobulin. Prophylactic use in risk patients].
Geursen RG
ZFA (Stuttgart); 1983 Mar; 59(7):342-7. PubMed ID: 6303013
[No Abstract] [Full Text] [Related]
8. Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus.
Miller E; Cradock-Watson JE; Ridehalgh MK
Lancet; 1989 Aug; 2(8659):371-3. PubMed ID: 2569560
[TBL] [Abstract][Full Text] [Related]
9. Prevention of varicella in immunocompromised patients on unpredictable occurrence of the disease in a children's ward: vaccine-boostered immune whole blood transfusion (VIB) method.
Hirao T
Biken J; 1984 Sep; 27(2-3):137-41. PubMed ID: 6100052
[TBL] [Abstract][Full Text] [Related]
10. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
[TBL] [Abstract][Full Text] [Related]
11. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
[TBL] [Abstract][Full Text] [Related]
12. [Primary infection with varicella-zoster virus in risk groups].
Jovanović J; Cvjetković D; Pobor M; Brkić S
Med Pregl; 1998; 51(3-4):151-4. PubMed ID: 9611959
[TBL] [Abstract][Full Text] [Related]
13. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of varicella in immunocompromised children. Clinical and serological evaluation of specific anti-varicella-zoster immunoglobulins].
Macchia P; Abadessa A; Nardi M; Consolini R; Conaldi PG; Bendinelli M
Minerva Pediatr; 1984 Nov; 36(21):1053-7. PubMed ID: 6099463
[No Abstract] [Full Text] [Related]
15. VariZIG for prophylaxis after exposure to varicella.
Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):69-70. PubMed ID: 16977283
[No Abstract] [Full Text] [Related]
16. Live attenuated varicella vaccine use in immunocompromised children and adults.
Gershon AA; Steinberg SP; Gelb L
Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
[TBL] [Abstract][Full Text] [Related]
17. VZV infection in pregnancy: a retrospective review over 5 years in Sheffield and discussion on the potential utilisation of varicella vaccine in prevention.
McKendrick MW; Lau J; Alston S; Bremner J
J Infect; 2007 Jul; 55(1):64-7. PubMed ID: 17418420
[TBL] [Abstract][Full Text] [Related]
18. [A new preparation of specific anti-varicella-zoster immunoglobulin. Clinical evaluation in immunodepressed subjects].
Miceli Sopo S; Pesaresi MA; Stabile A
Minerva Pediatr; 1987 Apr; 39(8):317-9. PubMed ID: 3614159
[No Abstract] [Full Text] [Related]
19. Transfer factor for the prevention of varicella-zoster infection in childhood leukemia.
Steele RW; Myers MG; Vincent MM
N Engl J Med; 1980 Aug; 303(7):355-9. PubMed ID: 6248780
[TBL] [Abstract][Full Text] [Related]
20. Towards evidence based medicine for paediatricians. How effective is varicella-zoster immunoglobulin (VZIG) in preventing chickenpox in neonates following perinatal exposure?
Tebruegge M; Pantazidou A; Curtis N
Arch Dis Child; 2009 Jul; 94(7):559-61. PubMed ID: 19542068
[No Abstract] [Full Text] [Related]
[Next] [New Search]
